NDC product
Dobutamine Hydrochloride in Dextrose
NDC 0338-1075 · Baxter Healthcare Corporation
Key facts
| Product NDC | 0338-1075 |
|---|---|
| Proprietary name | Dobutamine Hydrochloride in Dextrose |
| Nonproprietary name | Dobutamine Hydrochloride |
| Substances | DOBUTAMINE HYDROCHLORIDE |
| Dosage form | INJECTION |
| Route | INTRAVENOUS |
| Labeler | Baxter Healthcare Corporation |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA020255 |
| Pharmacologic classes | Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC] |
| Marketing start | Sep 27, 1993 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: